Response Rate in CLL Patients Treated with Obinutuzumab - Single Centre Experience from University Clinic of Hematology, Skopje
Authors
Olivera Gjeorgjieva Janev
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Tara Mojsovska
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Martin Stojanoski
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Marica Pavkovic
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Marija Popova Labachevska
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Lazar Chadievski
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Aleksandra Pivkova Veljanovska
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Zlate Stojanoski
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Sonja Genadieva Stavrikj
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, RN Macedonia
Language: English
Page range: 93 - 100
Published on: Mar 21, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Related subjects:
© 2026 Olivera Gjeorgjieva Janev, Tara Mojsovska, Martin Stojanoski, Marica Pavkovic, Marija Popova Labachevska, Lazar Chadievski, Aleksandra Pivkova Veljanovska, Zlate Stojanoski, Sonja Genadieva Stavrikj, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.